medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 5

<< Back

Gac Med Mex 2016; 152 (5)

Ictericia secundaria a obstrucción de vía biliar por enfermedad hepática poliquística: reporte de un caso

Ramírez-Guillén F, Rosas-Carrasco O, Cajuste-Sequeira F, Barriga-Pérez GB, Cabanillas-Morel A, Rosales-Salinas AE, Peña-Pérez JA
Full text How to cite this article

Language: Spanish
References: 17
Page: 715-718
PDF size: 237.31 Kb.


Key words:

Polycystic liver disease, Jaundice, Pruritus.

ABSTRACT

Abstract Polycystic liver disease is an autosomal dominant disorder commonly associated with autosomal dominant polycystic kidney disease. It is a rare disease that usually occurs asymptomatically in 85% of cases and diagnosis is incidentally. We present the case of 57 years old woman with progressive pruritus and jaundice secondary to stenosis of the common hepatic duct and common bile by liver cyst, rare presentation which only has been documented in case reports: Deepak, et al., Wittig, et al. and Howard, et al.


REFERENCES

  1. Deepak K, Shihab P, Sandesh K, Ramachadran T. Polycystic liver disease presenting as pruritus. Ann Gastroenterol. 2014;27:76-8.

  2. Wittig JH, Burns R, Longmire WP. Jaundice associated with polycystic liver disease. Am J Surg. 1978;136(3):383-6.

  3. Howard RJ, Hanson RF, Delaney JP. Jaundice associated with polycystic liver disease. Relief by surgical decompression of the cysts. Arch Surg. 1976;111(7):816-7.

  4. Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and Surgical Treatment Options for Polycystic Liver Disease. Hepatology. 2010;52(6):2223-30.

  5. Abu-Wasel B, Walsh C, Keough VM, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol. 2013;19(35):5775-86.

  6. Russell RT, Wright PC. Surgical management of Polycystic Liver Disease. World J Gastroenterol. 2007;13(38):5052-9.

  7. Desmet VJ. Ludwig symposium on biliary disorders. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc. 1998;73(Pt 1):80-9.

  8. Qi Qian. Isolated polycystic liver disease. Adv Chronic Kidney Dis. 2010;17(2):181-9.

  9. Igor-Macedo F. Current management of noninfectious hepatic cystic lesions: A review of the literature. World J Hepatol. 2013;5(9):462-9.

  10. Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic Liver Disease: Experience at a Teaching Hospital. Am J Gastroenterol. 2005;100:2212-7.

  11. Woolnough K, Palejwala A, Bramall S. Polycystic liver disease presenting with an exudative pleural effusion: a case report. J Med Case Rep. 2012;6:107.

  12. Macutkiewicz C, Plastow R, Chrispijn M, et al. Complications arising in simple and polycystic liver cysts. World J Hepatol. 2012;4:406-11.

  13. Spiros GD, Bakoyiannis A, Triantopoulou C, Paraskeva K. Obstructive Jaundice in Polycystic Liver Disease Related to Coexisting Cholangiocarcinoma. Rep Gastroenterol. 2008;2:162-9.

  14. Wybrich RC, Joost PH. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis. 2014;9:69.

  15. Rodríguez-Pérez JC. The role of mTOR inhibitors in renal diseases. Nefrology. 2011;31(3):251-5.

  16. Clinkscales NB, Trigg LP, Poklepovic J. Obstructive jaundice secondary to benign hepatic cyst. Radiology. 1985;54(3):643-4.

  17. Uddin W, Ramage JK, Portmann B, Wilson P, Benjamin I, Tan K-C, et al. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut. 1995;36:142-5.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2016;152